Drug Profile
Abafungin
Alternative Names: Abasol; W-6341; YP006; YP007Latest Information Update: 30 Sep 2009
Price :
$50
*
At a glance
- Originator York Pharma
- Class Antifungals; Imines; Phenyl ethers; Pyrimidines; Skin disorder therapies; Small molecules; Thiazoles
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Dermatomycoses; Onychomycosis; Vulvovaginal candidiasis
Most Recent Events
- 10 Aug 2009 Discontinued - Phase-III for Dermatomycoses in Europe (Topical)
- 10 Aug 2009 Discontinued - Phase-III for Dermatomycoses in Japan (Topical)
- 10 Aug 2009 Discontinued - Preclinical for Onychomycosis in United Kingdom (Topical)